Alverine
Lactose Intolerance
University of PecsSmall moleculeN/AActive
D
30/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 15/ 100
- Competitive Position
- 95/ 100
Competitive context
4 Active assets in the Lactose Intolerance cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Rp-G28 Ritter Pharmaceuticals, Inc. | Phase 3 | A |
Lactase University of Pecs | Phase 3 | BB |
Simethicone University of Pecs | N/A | D |
A2 beta-casein Purdue University | N/A | D |
Streptococcus thermophilus DSM 24731 Société des Produits Nestlé (SPN) | N/A | D |
View all 9 →
Same molecule, other indications
Alverine is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →